Protection by a cyclic AMP-specific phosphodiesterase inhibitor, rolipram, and dibutyryl cyclic AMP against Propionibacterium acnes and lipopolysaccharide-induced mouse hepatitis

Author: Taguchi I.   Oka K.   Kitamura K.   Sugiura M.   Oku A.   Matsumoto M.  

Publisher: Springer Publishing Company

ISSN: 1023-3830

Source: Inflammation Research, Vol.48, Iss.7, 1999-07, pp. : 380-385

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content